EP0819168A4 - Human tumor necrosis factor receptor - Google Patents
Human tumor necrosis factor receptorInfo
- Publication number
- EP0819168A4 EP0819168A4 EP95914722A EP95914722A EP0819168A4 EP 0819168 A4 EP0819168 A4 EP 0819168A4 EP 95914722 A EP95914722 A EP 95914722A EP 95914722 A EP95914722 A EP 95914722A EP 0819168 A4 EP0819168 A4 EP 0819168A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- receptor
- disclosed
- methods
- agonists
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000005962 receptors Human genes 0.000 title abstract 9
- 108020003175 receptors Proteins 0.000 title abstract 9
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 title abstract 2
- 102000057041 human TNF Human genes 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 3
- 239000000556 agonist Substances 0.000 abstract 2
- 239000005557 antagonist Substances 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 230000005860 defense response to virus Effects 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000012010 growth Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/003216 WO1996028546A1 (en) | 1995-03-15 | 1995-03-15 | Human tumor necrosis factor receptor |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0819168A1 EP0819168A1 (en) | 1998-01-21 |
EP0819168A4 true EP0819168A4 (en) | 2000-11-08 |
Family
ID=22248816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95914722A Withdrawn EP0819168A4 (en) | 1995-03-15 | 1995-03-15 | Human tumor necrosis factor receptor |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0819168A4 (en) |
JP (1) | JPH11503007A (en) |
AU (1) | AU2159995A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996026217A1 (en) * | 1995-02-20 | 1996-08-29 | Snow Brand Milk Products Co., Ltd. | Novel protein and methods for the production of the same |
-
1995
- 1995-03-15 JP JP8527539A patent/JPH11503007A/en active Pending
- 1995-03-15 EP EP95914722A patent/EP0819168A4/en not_active Withdrawn
- 1995-03-15 AU AU21599/95A patent/AU2159995A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996026217A1 (en) * | 1995-02-20 | 1996-08-29 | Snow Brand Milk Products Co., Ltd. | Novel protein and methods for the production of the same |
EP0816380A1 (en) * | 1995-02-20 | 1998-01-07 | Snow Brand Milk Products Co., Ltd. | Novel protein and methods for the production of the same |
Non-Patent Citations (6)
Title |
---|
C A SMITH ET AL: "A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 248, no. 248, 25 May 1990 (1990-05-25), pages 1019 - 1022-1023, XP002107350, ISSN: 0036-8075 * |
DATABASE WPI Section Ch Week 199640, Derwent World Patents Index; Class B04, AN 1996-402320, XP002131168 * |
KOHNO T ET AL: "A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1990 NOV) 87 (21) 8331-5., XP000872869 * |
LEWIS M ET AL: "CLONING AND EXPRESSION OF CDNAS FOR TWO DISTINCT MURINE TUMOR NECROSIS FACTOR RECEPTORS DEMONSTRATE ONE RECEPTOR IS SPECIES SPECIFIC", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,US,NATIONAL ACADEMY OF SCIENCE. WASHINGTON, vol. 88, 1 April 1991 (1991-04-01), pages 2830 - 2834, XP002029051, ISSN: 0027-8424 * |
SCHALL T J ET AL: "MOLECULAR CLONING AND EXPRESSION OF A RECEPTOR FOR HUMAN TUMOR NECROSIS FACTOR", CELL,US,CELL PRESS, CAMBRIDGE, NA, vol. 61, 20 April 1990 (1990-04-20), pages 361 - 370, XP002063264, ISSN: 0092-8674 * |
See also references of WO9628546A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP0819168A1 (en) | 1998-01-21 |
AU2159995A (en) | 1996-10-02 |
JPH11503007A (en) | 1999-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gruss | Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily | |
Kalthoff et al. | Tumor necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor alpha and epidermal growth factor receptor mRNA. | |
ES2154354T3 (en) | LIGANDOS TIE-2, METHODS TO OBTAIN THEM AND ITS USES. | |
WO2003057158A3 (en) | Method of treating apoptosis and compositions thereof | |
ATE364614T1 (en) | TUMOR NECROSIS FACTOR GAMMA | |
WO1998030694A3 (en) | TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b) | |
EP0823478A3 (en) | Human cartilege GP 39-like gene | |
HUP9902429A2 (en) | Modulators of tnf receptor associated factor (traf), their preparation and use | |
EP0821728A4 (en) | Tie-2 ligands, methods of making and uses thereof | |
EP0837131A3 (en) | Staphylococcus fibronectin binding protein compounds | |
AU1724795A (en) | Human tissue inhibitor of metalloproteinase-4 | |
Simpson et al. | Identification of a messenger ribonucleic acid fraction in human prostatic cancer cells coding for a novel osteoblast-stimulating factor | |
WO2000054651A3 (en) | Human tumor necrosis factor receptor-like genes | |
Sanceau et al. | Tumor necrosis factor-alpha and IL-6 up-regulate IFN-gamma receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms. | |
NZ288799A (en) | Human chemokine beta-9 polypeptides, polynucleotides encoding the chemokine and preparation thereof | |
CN103509814B (en) | A kind of recombinant expression method of grass carp tumor necrosis factor alpha gene | |
EP0812913A3 (en) | HR-1 receptor, a receptor of the cytokine receptors family | |
EP0819168A4 (en) | Human tumor necrosis factor receptor | |
CN116445491B (en) | Unmethylated CpG oligodeoxynucleotide and application thereof | |
DE69534705D1 (en) | DICKDARM SPECIFIC GENES AND PROTEINS | |
EP0808899A3 (en) | Human marco scavenger receptor (HMarcoSR) | |
Lobb et al. | Lysates of two established human tumor lines contain heparin-binding growth factors related to bovine acidic brain fibroblast growth factor | |
EP0835938A3 (en) | Topoisomerase I | |
DE102005013621A1 (en) | Substituted 2-aryl (hetaryl) -5-aminothieno [2,3-d] pyrimidine-6-carboxylic acid amides, process for their preparation and use as pharmaceuticals | |
CN1238052C (en) | Obtainment of cell growth inhibiting polypeptide and its usage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19971015 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 12N 15/00 A, 7C 12N 5/10 B, 7C 12N 5/00 B, 7C 12N 15/11 B, 7C 12N 15/28 B, 7C 12N 15/09 B, 7C 12N 15/63 B, 7C 07K 14/00 B, 7C 07K 14/525 B, 7C 12P 21/06 B, 7C 07K 14/705 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20000926 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20030808 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060612 |